Virtual Reality After Stroke: The Comparator Matters as Much as the Headset

Novel equipment does not settle effectiveness

Virtual rehabilitation can look different from conventional therapy without necessarily improving recovery. The comparison group and amount of practice are crucial. The 2025 Cochrane review covers approaches ranging from screen-based games to immersive rehabilitation systems. These differ in feedback, tracking, difficulty and therapist involvement, so pooled findings do not endorse every commercial product.

Replacement versus extra treatment

Replacing an equal amount of conventional therapy asks whether a delivery method is more effective. Adding virtual practice to usual care may give one group more total rehabilitation. Improvement then cannot automatically be attributed to immersion rather than extra practice. This distinction was already important in the 2017 review and remains important in the update.

Publication date is not search date

The newer review searched trial registries through September 2023. A 2025 publication therefore should not be described as including every development through 2025. It prioritizes upper-limb function and activity while considering mobility, cognition, daily activities, participation, quality of life and adverse events. Better performance inside a game should not substitute for those broader outcomes.

Questions before adopting a system

Study quality, participant selection, dose and differences between devices affect interpretation. A task score does not prove a particular neuroplastic mechanism. Selected participants may differ from people with significant visual, cognitive or balance difficulties. Ask what real-life goal the device targets, whether it adds or replaces practice and how progress is checked outside software. Screening and supervision matter with immersive equipment. Cost and novelty are not effectiveness measures. The program should fit the person and clinical goal, not the other way around.

This evidence supports informed conversations, not an individualized prediction. Study populations and comparison conditions matter when considering how findings apply to a particular person. Bring your priorities and questions to a qualified professional who can assess your circumstances.

Sources

• Laver et al., 2025: Updated Cochrane review
• Laver et al., 2017: Earlier review

This article is for general information, not individual medical advice. Illustration is AI-generated and does not depict actual study participants.